caa a22 4500 463179420 CHVBK 20180406164834.0 cr unu---uuuuu 170326e20070901xx s 000 0 eng 10.1007/s00381-007-0397-3 doi (NATIONALLICENCE)springer-10.1007/s00381-007-0397-3 Albright A. Department of Neurosurgery, University of Wisconsin Health Center, Room K4-836, 600 Highland Ave., 53792, Madison, WI, USA aut Intrathecal baclofen for childhood hypertonia [Elektronische Daten] [A. Albright] Introduction: Intrathecal baclofen was first introduced in 1985 to manage childhood hypertonia. There has been an evolution in thought as to how candidates should be identified and what forms of hypertonia respond to this treatment. Purpose: This manuscript reviews the pharmacology of the drug, the assessment of candidates, the implantation of the infusion pump, and the usual doses delivered. Side effects and complications are reviewed as are outcomes. Springer-Verlag, 2007 Intrathecal baclofen nationallicence CSF infusion pump nationallicence Childhood hypertonia nationallicence Spasticity nationallicence Dystonia nationallicence Mixed hypertonia nationallicence Child's Nervous System Springer-Verlag 23/9(2007-09-01), 971-979 0256-7040 23:9<971 2007 23 381 https://doi.org/10.1007/s00381-007-0397-3 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00381-007-0397-3 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Albright A. Department of Neurosurgery, University of Wisconsin Health Center, Room K4-836, 600 Highland Ave., 53792, Madison, WI, USA aut NATIONALLICENCE 773 0- Child's Nervous System Springer-Verlag 23/9(2007-09-01), 971-979 0256-7040 23:9<971 2007 23 381 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer